Page last updated: 2024-11-05

troglitazone and Infertility, Female

troglitazone has been researched along with Infertility, Female in 2 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Infertility, Female: Diminished or absent ability of a female to achieve conception.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schröder, AK1
Tauchert, S1
Ortmann, O1
Diedrich, K1
Weiss, JM1
Mitwally, MF1
Kuscu, NK1
Yalcinkaya, TM1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Efficacy and Safety of Furocyst in Patients With Poly Cystic Ovary Syndrome[NCT02789488]Phase 450 participants (Actual)Interventional2013-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for troglitazone and Infertility, Female

ArticleYear
[Insulin resistance in polycystic ovary syndrome].
    Wiener klinische Wochenschrift, 2003, Dec-15, Volume: 115, Issue:23

    Topics: Adolescent; Adult; Body Mass Index; Cardiovascular Diseases; Chromans; Controlled Clinical Trials as

2003

Other Studies

1 other study available for troglitazone and Infertility, Female

ArticleYear
High ovulatory rates with use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome.
    Human reproduction (Oxford, England), 1999, Volume: 14, Issue:11

    Topics: Adult; Body Temperature; Chromans; Clomiphene; Drug Resistance; Female; Humans; Infertility, Female;

1999